Curateai Labs Pvt Ltd·14h agoCracking MONALEESA-2: A Beginner’s Guide to Reading Cancer Trial DataWritten By Umakant B — AI Engineer @ Curate ai
Vinaitheerthan Renganathan·1d agoBeyond the Point Estimate: A Comprehensive Guide to Bootstrapping in Clinical ResearchUnderstanding Non-Parametric Resampling, Confidence Interval Construction (Percentile vs. BCa), Handling Clustered Clinical Trials, and…
David Mokotoff, MD·1d agoI Asked AI For The Heart Healthiest Diet, And It Was UnanimousOnce again, the Mediterranean Diet is affirmed as best for your heart.A response icon1A response icon1
Ahmed M. Hala·4d agoThe Confounder Is the SignalSix things that stop being obvious the moment you try to prove a new medical test worksA response icon1A response icon1
Anastasia Shapovalova·4d agoBefore You Trust Your Metrics: A CM Checklist for Data Collection DesignThis post should be viewed only as my personal opinion.
Amino Insider·Oct 29BPC-157 Has Five Human Studies and Its Loudest Advocate Just Trashed OneBy Dr. William Seeds’ own count, BPC-157 (Body Protection Compound 157) is probably the most widely used peptide on earth. In the same…A response icon2A response icon2
Julien Dimastromatteo, PhD·Oct 29What a Pre-IND Meeting Can and Cannot DoWhat sponsors can ask FDA before an IND and what the answer does not mean.
Lifeflexi·Oct 29Micro-Randomized Trials for JITAI Clinical ResearchClinical Trial Design * Digital Health Methods * October 29, 2026
Wendi Carroll·Oct 28Rare Disease Approvals: Do You Know Where the Data Came From?Why natural history data matters for rare disease approvals, and why patients pay when it is planned too late
phaware global association®·Oct 27I’m Aware That I’m Rare: Daniel Lachant, MD (596)the phaware® interview
